Stay updated on CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page.

Latest updates to the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.4.2 was added and earlier notices about funding and operating status were removed. These are administrative site updates that do not affect trial data or core page content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check17 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's operations. Updated the site version to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.8%

- Check24 days agoChange DetectedThe history view received minor UI updates, including a Show glossary option, color-coded highlight explanations, and an updated revision tag (v3.4.0 replacing v3.3.4). These changes do not affect core trial data or content, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check60 days agoChange DetectedRevision: v3.3.3 has been added to the study history, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check81 days agoChange DetectedA new revision (v3.3.2) was added, replacing the previous v3.3.1, which appears to be a minor update to the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision: v3.3.1 was added and Revision: v3.2.0 was removed from the Study Record History.SummaryDifference0.1%

Stay in the know with updates to CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page.